Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia

G. Meachery, L. Archer, A. De Soyza, G. Parry, S. Clark, K. Tocewicz, A. Fisher, J. Lordan, S. Schueler, K. Gould, J. Dark, P. Corris (Newcastle Upon Tyne, United Kingdom)

Source: Annual Congress 2007 - New insights into clinical lung transplantation
Session: New insights into clinical lung transplantation
Session type: Electronic Poster Discussion
Number: 332
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Meachery, L. Archer, A. De Soyza, G. Parry, S. Clark, K. Tocewicz, A. Fisher, J. Lordan, S. Schueler, K. Gould, J. Dark, P. Corris (Newcastle Upon Tyne, United Kingdom). Survival outcomes following lung transplantation for cystic fibrosis patients infected with Burkholderia cenocepacia. Eur Respir J 2007; 30: Suppl. 51, 332

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Burkholderia cepacia infection in adult cystic fibrosis patients: Its impact on lung function and survival
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010

Taurolidine in the management of lung transplant recipients with cystic fibrosis colonized with burkholderia cepacia
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002

Early diagnostics of Burkholderia cenocepacia improves survival rate in patients with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 615s
Year: 2004

Treatment of Burholderia cepacia infection in patients with cystic fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 539s
Year: 2001

Changes in local and systemic inflammatory markers in cystic fibrosis patients chronically infected with Burkholderia cepacia complex
Source: Virtual Congress 2020 – Microbiology and antimicrobial strategies in cystic fibrosis
Year: 2020


Burkholderia cepacia complex infection in Czech patients with cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 503s
Year: 2003

Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005

Epidemiology of Burkholderia cepacia complex colonisation in cystic fibrosis patients
Source: Eur Respir J 2004; 23: 851-856
Year: 2004



Survival and lung function in double lung transplant recipients with cystic fibrosis
Source: International Congress 2017 – From donor lung selection and organ preservation to lung transplant outcome
Year: 2017

Outcomes and survival following lung transplantation in non-cystic fibrosis bronchiectasis
Source: ERJ Open Res, 8 (1) 00607-2021; 10.1183/23120541.00607-2021
Year: 2022



Survival benefit of lung transplantation for cystic fibrosis in Norway
Source: International Congress 2019 – Lung transplantation: from basic science to clinical outcomes
Year: 2019


Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Colonization of bacteria after lung transplantation in cystic fibrosis (CF) patients occurs early but does not impact survival
Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment
Year: 2015


The impact of colonization with therapy-resistant pathogens on the survival rate after lung transplantation (LUTX) in cystic fibrosis (CF)
Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?
Year: 2021



Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis
Source: Eur Respir J 2002; 20: Suppl. 38, 347s
Year: 2002

Nebulized heparin in Burkholderia cepacia colonized adult cystic fibrosis patients
Source: Eur Respir J 2001; 17: 36-38
Year: 2001



Isolation of Achromobacter xylosoxidans from the respiratory secretions of patients with cystic fibrosis: frequency in the population and significance to the progression of lung disease
Source: Eur Respir J 2005; 26: Suppl. 49, 402s
Year: 2005

Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018




Inhaled colistin following lung transplantation in colonised cystic fibrosis patients
Source: Eur Respir J 2013; 42: 542-544
Year: 2013